BCL9, a coactivator for Wnt/β-catenin transcription, is targeted by miR-30c and is associated with prostate cancer progression

B-cell lymphoma 9 (BCL9), a component of aberrantly activated Wnt signaling, is an important contributing factor to tumor progression. Our previous data indicated that downregulation of the tumor suppressor microRNA-30c (miR-30c) was a frequent pathogenetic event in prostate cancer (PCa). However, a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Lett
Main Authors: LING, XIAO-HUI, CHEN, ZHI-YUN, LUO, HONG-WEI, LIU, ZE-ZHEN, LIANG, YING-KE, CHEN, GUAN-XING, JIANG, FU-NENG, ZHONG, WEI-DE
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2016
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4774446/
https://ncbi.nlm.nih.gov/pubmed/26998113
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.4161
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados